Abstract
In this study, we propose a personalized glucose prediction model using deep learning for hospitalized patients who experience Type-2 diabetes. We aim for our model to assist the medical personnel who check the blood glucose and control the amount of insulin doses. Herein, we employed a deep learning algorithm, especially a recurrent neural network (RNN), that consists of a sequence processing layer and a classification layer for the glucose prediction. We tested a simple RNN, gated recurrent unit (GRU), and long-short term memory (LSTM) and varied the architectures to determine the one with the best performance. For that, we collected data for a week using a continuous glucose monitoring device. Type-2 inpatients are usually experiencing bad health conditions and have a high variability of glucose level. However, there are few studies on the Type-2 glucose prediction model while many studies performed on Type-1 glucose prediction. This work has a contribution in that the proposed model exhibits a comparative performance to previous works on Type-1 patients. For 20 in-hospital patients, we achieved an average root mean squared error (RMSE) of 21.5 and an Mean absolute percentage error (MAPE) of 11.1%. The GRU with a single RNN layer and two dense layers was found to be sufficient to predict the glucose level. Moreover, to build a personalized model, at most, 50% of data are required for training.
Highlights
Diabetes is a major risk factor for patients suffering from various diseases including cardiovascular disease [1]
We proposed a personalized glucose prediction model using deep learning for hospitalized patients suffering from Type-2 diabetes
Medical personnel check blood glucose and control insulin doses, and they mainly rely on their domain knowledge of the glucose levels measured in the ward
Summary
Diabetes is a major risk factor for patients suffering from various diseases including cardiovascular disease [1]. It is critical to thoroughly monitor, predict, and regulate blood glucose in diabetic patients. Most previous studies on the prediction of blood glucose were conducted on outpatients, and most of these patients were those with Type-1 diabetes [6,7,8,9,10,11]. Inpatients have higher risk of hyperglycemia and hypoglycemia for reasons such as instability of vital signs due to various diseases, stress, and inflammation, immune responses, and drugs administered for treatment [12,13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.